RxDoctor Payments Data

Jay Fuller

Optometrist · Gulfport, MSNPI 1053667758

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (55.4%), food and beverage and education — rather than concentrated in one kind of arrangement. Carl Zeiss Meditec USA, Inc. accounts for 61.1% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $2,586 and has fallen 86.0% since, to $362 in 2025. Among optometrist clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,705in general payments, 2019–2025

Across 50 payments — averaging $114.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Carl Zeiss Meditec USA, Inc.$3K
  • Alcon$608
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$410
  • Bausch & Lomb Americas Inc.$351
  • Glaukos Corporation$259
  • Kala Pharmaceuticals, Inc.$124
  • plus $468 from 7 others

What the payments were for

  • Travel & lodging$3,16355%
  • Food & beverage$2,44243%
  • Education$1002%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,705 in reported general payments places this provider in the 90th percentile of 372 optometrist providers in Mississippi.

See all optometrist providers in Mississippi

Medicare billing

Part B allowed, 2024
$59,181
Medicare patients
254
Services billed
647

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine35$42,071
LumiganBimatoprost15$3,890
Travoprost18$2,920
Fluorometholone18$1,399
Latanoprost156$1,078
Timolol Maleate91$808
Tobramycin-DexamethasoneTobramycin/Dexamethasone16$770
Prednisolone Acetate14$518
Brimonidine Tartrate30$277
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha23$261

Paid to pharmacies, not to this prescriber.

Other optometrist in Gulfport

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →